473733-69-6

Upstream product

• 2941-20-0 1-phenylpropylamine 
• 5231-87-8 3,4-diethoxy-3-cyclobuten-1,2-dione 

Downstream Products

• 1383427-76-6 C₂₇H₃₁ClN₄O₆S 
• 1255914-16-9 (R)-4-(3,4-dioxo-2-(1-phenylpropylamino)cyclobut-1-enylamino)-3-hydroxy-N,N-dimethylpicolinamide 
• 1255306-07-0 (R)-3-amino-4-(1-phenyl-propylamino)-cyclobut-3-ene-1,2-dione 
• 473730-92-6 C₂₀H₁₈N₂O₅ 

Relevant academic research and scientific papers

CYCLOBUTENEDIONE DERIVATIVES

The present invention relates to compounds of the formula (I): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly inflammatory conditions.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.